Elevai

Featured

ELEVAI Labs: A Strategic Expansion in Biosciences and Skincare

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…

Read More »
Biotech

ELEVAI Labs Posts Record Full Year 2023 and Q4 Earnings

The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…

Read More »
Top Stories

ELEVAI Labs Posts Q3 2023 Earnings, Reports Record Quarterly Revenue

ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…

Read More »
Top Stories

ELEVAI Labs Expands Into European Market With Signing of New Partnership

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…

Read More »
Biotech

ELEVAI Labs Inks Licensing Deal With Yuva Biosciences to Develop New Topical Skincare Formulations and Aesthetics Products (VIDEO)

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…

Read More »
Top Stories

ELEVAI Labs Announces Pricing of $6 Million IPO

Shares of Elevai Labs have been approved for listing on the NASDAQ and Will Commence Trading on November 21, 2023,…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…

Read More »
Top Stories

ELEVAI Labs Announces New Exclusive Philippines Distributor Partnership

ELEVAI Labs, a medical aesthetic biotechnology company focused on physician-dispensed skincare and a leader in exosome research and development, is…

Read More »
Top Stories

ELEVAI Labs to Accelerate and Expand its Work With Stem Cell-Derived Exosomes After Securing New Research Partnership and Non-Repayable Grant

ELEVAI Labs, a medical aesthetic biotechnology company specializing in physician-dispensed skincare, reported today that it secured a stem cell exosome…

Read More »
Biotech

ELEVAI Labs Unveils New Paradigm-Shifting Skincare Procedure to the American Society for Laser Medicine and Surgery (ASLMS)

ELEVAI Labs, a science-based, data-driven aesthetic skincare company, will launch its revolutionary core technology platform, PREx™ (Precision Regenerative Exosome Technology™),…

Read More »
Back to top button